Opportunities and obstacles in microbial synthesis of metal nanoparticles.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101316335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-7915 (Electronic) Linking ISSN: 17517915 NLM ISO Abbreviation: Microb Biotechnol Subsets: MEDLINE

Publication: Hoboken, NJ : Wiley-Blackwell
Original Publication: Oxford : Blackwell, c2008-

Metal Nanoparticles* ; Anti-Infective Agents* ; Nanostructures* ; Nanoparticles*

Metallic nanoparticles (MeNPs) are widely used in many areas such as biomedicine, packaging, cosmetics, colourants, agriculture, antimicrobial agents, cleaning products, as components of electronic devices and nutritional supplements. In addition, some MeNPs exhibit quantum properties, making them suitable materials in the photonics, electronic and energy industries. Through the lens of technology, microbes can be considered nanofactories capable of producing enzymes, metabolites and capping materials involved in the synthesis, assembly and stabilization of MeNPs. This bioprocess is considered more ecofriendly and less energy intensive than the current chemical synthesis routes. However, microbial synthesis of MeNPs as an alternative method to the chemical synthesis of nanomaterials still faces some challenges that need to be solved. Some of these challenges are described in this Editorial.
(© 2023 The Authors. Microbial Biotechnology published by Applied Microbiology International and John Wiley & Sons Ltd.)

PLoS Biol. 2012;10(2):e1001269. (PMID: 22389629)
Microb Cell Fact. 2016 Jun 14;15(1):109. (PMID: 27301452)
Biochem Soc Trans. 2020 Aug 28;48(4):1367-1378. (PMID: 32627824)
Crit Rev Biotechnol. 2015 Mar;35(1):114-28. (PMID: 23937251)
World J Microbiol Biotechnol. 2016 Sep;32(9):156. (PMID: 27465856)
J Ind Microbiol Biotechnol. 2010 Oct;37(10):1023-31. (PMID: 20544257)
Proc Natl Acad Sci U S A. 2018 Jun 5;115(23):5944-5949. (PMID: 29784775)
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13480-5. (PMID: 21808043)
Biol Res. 2022 Apr 5;55(1):17. (PMID: 35382884)
Microb Biotechnol. 2021 Jan;14(1):198-212. (PMID: 33068075)
Front Microbiol. 2022 Mar 21;13:855077. (PMID: 35387087)
Annu Rev Plant Biol. 2002;53:159-82. (PMID: 12221971)
Front Microbiol. 2021 Jun 04;12:658294. (PMID: 34149647)
J Biol Chem. 2004 Dec 3;279(49):50662-9. (PMID: 15371444)
N Biotechnol. 2014 Dec 25;31(6):572-8. (PMID: 24681407)
J Biotechnol. 2012 Dec 31;162(2-3):237-45. (PMID: 23036923)
Appl Microbiol Biotechnol. 2016 Jan;100(2):521-34. (PMID: 26300292)
Microb Biotechnol. 2023 May;16(5):931-946. (PMID: 36682039)
Front Microbiol. 2019 Mar 08;10:410. (PMID: 30906287)
Sci Technol Adv Mater. 2013 Dec 3;15(1):014401. (PMID: 27877637)
Nat Nanotechnol. 2012 Dec;7(12):779-86. (PMID: 23212421)
Sci Rep. 2018 Mar 2;8(1):3923. (PMID: 29500440)
Appl Microbiol Biotechnol. 2016 Sep;100(18):7921-31. (PMID: 27118014)
Microb Cell Fact. 2013 Aug 06;12:75. (PMID: 23919572)
Front Chem. 2021 Apr 16;9:626834. (PMID: 33937188)
Microb Biotechnol. 2023 May;16(5):915-930. (PMID: 36366868)
Trends Biotechnol. 2016 Jul;34(7):588-599. (PMID: 26944794)
Front Bioeng Biotechnol. 2022 Apr 06;10:874742. (PMID: 35464722)
Int J Nanomedicine. 2015 Jan 29;10:963-74. (PMID: 25673991)
RSC Adv. 2019 Apr 26;9(23):12944-12967. (PMID: 35520790)
Sci Rep. 2017 Nov 22;7(1):16046. (PMID: 29167550)
Molecules. 2019 Jul 11;24(14):. (PMID: 31373294)
Nanomedicine. 2010 Apr;6(2):257-62. (PMID: 19616126)
Int J Nanomedicine. 2020 Aug 13;15:6033-6066. (PMID: 32884261)
Appl Microbiol Biotechnol. 2021 Jul;105(13):5357-5366. (PMID: 34184105)

0 (Anti-Infective Agents)

Date Created: 20230325 Date Completed: 20230427 Latest Revision: 20230509

20240829

PMC10128127

10.1111/1751-7915.14254

36965145